Announcements
Mitsubishi Tanabe Pharma to be removed from Nikkei 300
Stock will also be deleted from Nikkei 500 and JPX-Nikkei Index 400
Pharmaceuticals
Travel & Leisure
From cars to whisky, industrial tourism takes off in Japan
Nine heritage sites reveal the secrets of the nation's economic success
Cover Story
What Japan Inc. really thinks about Ghosn, Nissan's maverick savior
Carlos Ghosn's downfall sets up a clash between Japan's old guard and its reformists
Pharmaceuticals
Takeda taps Shire's global network to sell prized dengue vaccine
Japanese drugmaker to utilize sales channels from massive acquisition
Banking & Finance
Nomura regains crown as Japan's top M&A adviser
Major all-domestic deals and streamlining push give local players an edge
Business trends
Japan's M&A boom put to test as recession fears loom
2019 deal count hits record as companies face shrinking growth at home
Nikkei Markets
Asian stocks decline as uncertainties linger on US-China trade pact
Taiwan Semiconductor, Tencent among losers on A300
Business deals
Japan's Astellas Pharma to buy US gene therapy specialist for $3bn
Deal targets Audentes' 'robust pipeline' in one of the hottest research fields
Nikkei Markets
Asian stocks rise after China manufacturing posts surprise gain
Indian mobile phone operators jump on plan to raise tariffs
Nikkei Markets
Singapore manufacturing grows at 11-month high, tech recovers
Recent data suggest economy may grow faster than expected
